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Piergiorgio Cao, MD, FRCS, Editor-in-Chief, and Jean-Baptiste Ricco, MD, PhD, Senior EditorSynchronous Carotid Endarterectomy and Off-pump Coronary By-
pass: An Updated, Systematic Review of Early Outcomes
Fareed K.R., Rothwell P.M., Mehta Z., Naylor A.R. Eur J Vasc Endovasc
Surg 2009;xx:xx-xx.
Objectives: To update our previous systematic review of outcomes
following synchronous carotid endarterectomy (CEA) and off-pump coro-
nary artery bypass grafting (OFF-CABG).
Design: A systematic review of operative risks reported in published
studies of synchronous CEA plus OFF-CABG procedures.
Results: We identified 12 eligible studies, including data on 324
synchronous CEA plus OFF-CABG procedures. Operative mortality was
1.5% (95% confidence interval (CI): 0.3–2.8), the risk of death or ipsilateral
stroke was 1.6% (0.4–2.8%), risk of death or any stroke was 2.2% (95% CI:
0.7–3.7) and the risk of death, stroke ormyocardial infarction was 3.6% (95%
CI: 1.6–5.5).
Conclusions: Limited published data on 324 patients suggest that
early outcomes after synchronous CEA plus OFFCABG are better than
those following staged or synchronous CEA plus CABG where the cardiac
procedure was performed on-pump. This may, however, be attributed to
publication bias, case selection or the fact that the aorta was not manipulated
or cannulated, rather than CEA being primarily responsible for the lower
stroke risk. Colleagues with unpublished experience of CEA plus OFF-
CABG are encouraged to submit their data to further inform the debate.
A Systematic Review and Meta-analysis of 30-Day Outcomes Follow-
ing Staged Carotid Artery Stenting and Coronary Bypass
Naylor A. Ross, Mehta Z., Rothwell P.M. Eur J Vasc Endovasc Surg
2009;xx:xx-xx.
Objectives: To determine the overall operative risk of cardiovascular
events in patients with combined cardiac and carotid artery disease under-
going staged carotid artery stenting (CAS) and coronary artery bypass
grafting (CABG).
Design: Systematic review of operative risks reported in all published
studies of CAS plus CABG procedures.
Results: Eleven eligible, published studies were identified which re-
ported data on 760 CAS plus CABG procedures. The majority of patients
(87%) were neurologically asymptomatic and 82% had unilateral carotid
stenoses. Overall mortality was 5.5% (95% confidence interval, CI: 3.4–7.6),
the risk of suffering an ipsilateral stroke was 3.3% (95% CI: 1.6–5.1) and the
risk of suffering ‘any’ stroke was 4.2% (95% CI: 2.4–6.1), while the 30-day
risk of myocardial infarction (MI) was only 1.8% (95% CI: 0.5–3.0). How-
ever, the 30-day death and ipsilateral stroke rate was 7.5% (95% CI: 4.5–
10.5) and the 30-day risk of death and any stroke was 9.1% (95% CI:
6.1–12.0), while the 30-day of death/stroke/MI was 9.4% (7.0–11.8).
Cumulative risks in studies where patients underwent CABG within 48 h of
CAS were not higher than in comparable studies where CABG was delayed
by more than 2 weeks.
Conclusions: In a cohort of predominantly asymptomatic patients
with unilateral carotid disease, the 30-day risk of death/any stroke was 9.1%.
These data are comparable to previous systematic reviews evaluating the
roles of staged and synchronous carotid endarterectomy (CEA) plus CABG,
and suggest that staged CAS plus CABG is an attractive and less invasive
alternative to CEA plus CABG. However, it remains questionable whether
the observed 9% risks can be justified in any asymptomatic patient with
unilateral carotid disease.
Serum Myoglobin and Renal Morbidity and Mortality following Tho-
racic and Thoraco-Abdominal Aortic Repair: Does Rhabdomyolysis
Play a Role?
Miller C.C. III, Villa M.A., Sutton J., Lau D., Keyhani K., Estrera A.L.,
Azizzadeh A., Coogan S.M., Safi H.J. Eur J Vasc Endovasc Surg 2009;xx:
xx-xx.
Objectives: The intractability of renal dysfunction following thoracic
and thoraco-abdominal aortic repair leads us to believe that the accepted
mechanisms of renal injury – ischaemia and embolism – are incompletely
explanatory. We studied postoperative myoglobinaemia and renal dysfunc-
tion following aortic surgery.
1086Methods: Between September 2006 and February 2008, we studied
serum myoglobin in 109 patients requiring thoracic/thoraco-abdominal
repair for three postoperative days. Forty-two of the 109 (38%) patients were
female. The median age was 67 years (range 23–84 years). As we have
focussed more attention on renal function, our independent renal consult-
ants have dialysed more aggressively. We divided dialysis into: (1) creatinine
indication, (2) non-creatinine indication and (3) no dialysis.
Results: Thirteen of the 109 (12%) patients met creatinine indication
for dialysis (4 mg dl1) and an additional 28 (26%) were dialysed for other
reasons. Overall mortality was 12 out of 109 (11%) cases: 11 out of 41 (27%)
in dialysed patients and one out of 68 (1.5%) in non-dialysed patients.
Mortality did not differ between the indications for dialysis. Predictors of
mortality were baseline glomerular filtration rate (GFR), postoperative
myoglobin and dialysis. The only predictor of dialysis was postoperative
myoglobin.
Conclusion: A strong relationship between postoperative serum myo-
globin and renal failure suggests a rhabdomyolysis-like contributing aetiol-
ogy following thoraco-abdominal aortic repair. We postulate a novel mech-
anism of renal injury for which mitigation strategies should be developed.
Is Endovascular Repair of Mycotic Aortic Aneurysms a Durable Treat-
ment Option?
Clough R.E., Black S.A., Lyons O.T., Zayed H.A., Bell R.E., Carrell T.,
WalthamM., Sabharwal T., Taylor P.R. Eur J Vasc Endovasc Surg 2009;xx:
xx-xx.
Objective: Endovascular repair for degenerative aortic aneurysms is
well established, but its role in those with infective pathology remains
controversial. This study aims to assess the durability of endovascular repair
with a review of our midterm results.
Method: A retrospective analysis of a prospectively maintained endo-
vascular database (1998–2008) was conducted, which identified 673 con-
secutive patients with aortic aneurysms.
Results: Nineteen patients (2.8%) were identified with infected aortic
aneurysms, in which there were a total of 23 separate aneurysms (16 thoracic
and seven abdominal). Six patients (32%) presented with rupture. Eleven
patients (58%) had received antibiotics preoperatively for a median duration
of 11 days (1–54 days). Fifteen of the 19 (79%) had positive blood cultures,
with Staphylococcus aureus being the most common organism.
All 19 patients underwent endovascular repair. There were three Type
I endoleaks (one requiring conversion to open repair) and two Type II
endoleaks. One patient developed transient paraplegia, resolved by cerebro-
vascular fluid (CSF) drainage, and one patient had a stroke.
The 30-day mortality was 11%, and survival at median follow-up of 20
months (0–83 months) was 73%. All eight deaths in the series were related
to aneurysm.
Conclusion: Endovascular treatment of infective aortic pathology
provides an early survival benefit; however, concerns over on-going graft
infection remain.
Is There a Benefit of Frequent CT Follow-up After EVAR?
Dias N.V., Riva L., Ivancev K., Resch T., Sonesson B., MalinaM. Eur J Vasc
Endovasc Surg 2009;xx:xx-xx.
Objective: Imaging follow-up (FU) after endovascular aneurysm repair
(EVAR) is usually performed by periodic contrast-enhanced computed
tomography (CT) scans. This study aims to evaluate the effectiveness of
CT-FU after EVAR.
Methods: In this study, 279 of 304 consecutive patients (261 male,
aged 74 years (interquartile range (IQR): 70–79 years) with a median
abdominal aortic aneurysm (AAA) diameter of 58 mm (IQR: 53–67 mm))
underwent at least one of the yearly CT scans and plain abdominal films after
EVAR. All patients received Zenith stent-grafts for non-ruptured AAAs at a
single institution. Patients were considered asymptomatic when a re-inter-
vention was done solely due to an imaging FU finding. The data were
prospectively entered in a computer database and retrospectively analysed.
Results: As a follow-up, 1167 CT scans were performed at a median of
54 months (IQR: 34–74 months) after EVAR. Twenty-seven patients
exhibited postoperative AAA expansion (a 5-year expansion-free rate of
88  2%), and 57 patients underwent 78 postoperative re-interventions
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(9.3%) undergoing imaging FU benefitted from the yearly CT scans, since
they had re-interventions based on asymptomatic imaging findings: AAA
diameter expansion with or without endoleaks (n  18), kink in the stent-
graft limbs (n  4), endoleak type III due to stent-graft limb separation
without simultaneous AAA expansion (n  2), isolated common iliac artery
expansion (n  1) and superior mesenteric artery malperfusion due to
partial coverage by the stent-graft fabric (n  1).
Conclusions: Less than 10% of the patients benefit from the yearly
CT-FU after EVAR. Only one re-intervention due to partial coverage of a
branch by the stent-graft would have been delayed if routine FU had been
based on simple diameter measurements and plain abdominal radiograph.
This suggests that less-frequent CT is sufficient in the majority of patients,
which may simplify the FU protocol, reduce radiation exposure and the total
costs of EVAR. Contrast-enhanced CT scans continue, nevertheless, to be
critical when re-interventions are planned.
Combined Primary Subintimal and Endoluminal Angioplasty for Isch-
aemic Inferior-limb Ulcers in Diabetic Patients: 5-year Practice in a
Multidisciplinary ‘Diabetic-Foot’ Service
Alexandrescu V., Hubermont G., Philips Y., Guillaumie B., Ngongang Ch.,
Coessens V., Vandenbossche P., Coulon M., Ledent G., Donnay J.-C. Eur
J Vasc Endovasc Surg 2009;xx:xx-xx.
Introduction:This study aims to assess the patency, the clinical success
and the limb-salvage rates of combined subintimal (SA) coupled to endolu-
minal angioplasty (EA) as the initial treatment of ischaemic inferior-limb
ulcers in diabetic patients and to study the influence of other concurrent
factors in the tissue-healing process.
Materials and method: Since September 2002 until December 2007,
a consecutive series of 176 limbs with manifold ischaemic wounds in 161
diabetic patients were treated by associated multilevel angioplasties in a
multidisciplinary ‘diabetic-foot team’ (a third-line diabetic-care institution
integrating two departmental hospitals). There were 98 associated SA with
EA procedures, 26 re-vascularisations by single SA technique and 52 others
including selective multilevel EAs that were retrospectively reviewed. The
mean follow-up period was 22.1 months (in the range of 1–50 months) by
clinical and duplex evaluation (every 6 months).
Results: The initial technical success was noted in 149 limbs (84%). For
the single or associated SA procedures, 102 of 124 procedures were successful
(82%) and 145 of 150 of the miscellaneous EAs (96%) evinced an equally
favourable outcome. The 27 initially failed endovascular procedures (22 SA and
five EA) required 16 surgical re-vascularisation, eight adjuvant endovascular
procedures besides three amputations. A total of 21 secondary and five tertiary
angioplasties were equally necessary during the entire follow-up period of these
patients. The 30-day survival rate was 99% (one patient died from myocardial
infarction). In a intention-to-treat analysis, the cumulative primary and second-
ary patencies at 12, 24, 36 and 48 months were 62%, 45%, 41% and 38%,
together with 80%, 69%, 66% and 66%, respectively. The aggregate clinical
success rates at the same intervals were 86%, 77%, 70% and 69%, while the
corresponding limb-salvage proportions showed 89%, 83%, 80% and 80%,
respectively. The primary patency was negatively affected at 1 and 4 years by the
length of the occluded segment (10 cm) and the end-stage renal disease
(ESRD) (p 0.0001). The limb-salvage rates were unfavourably influenced at
the same periods by the extent of tissue defects (3 cm), the ESRD and the
presence of osteomyelitis. In addition, at 4 years, the age (70 years), the
accompanying peripheral neuropathy, the bedridden status and the presence of
cardiac failure (left ventricular ejection fraction (LVEF) 30%) appeared
equally as negative predictors (p 0.0001) for wound healing and limb rescue.
Conclusion: Primary angioplasty represents a low aggressive and effi-achieving satisfactory limb-salvage rates probably implies a multidisciplinary
control of the presenting risk factors for wound healing as well.
Dacron or ePTFE for Femoro-popliteal Above-Knee Bypass Grafting:
Short- and Long-term Results of a Multicentre Randomised Trial
van Det R.J., Vriens B.H.R., van der Palen J., Geelkerken R.H. Eur J Vasc
Endovasc Surg 2009;xx:xx-xx.
Objectives: To compare expanded polytetrafluoroethylene (ePTFE)
prosthesis and collagen-impregnated knitted polyester (Dacron) for above-
knee (AK) femoro-popliteal bypass grafts.
Design: A prospective multicentre randomised clinical trial.
Patients and Methods: Between 1992 and 1996, 228 AK femoro-
popliteal bypass grafts were randomly allocated to either an ePTFE
(n  114) or a Dacron (n  114) vascular graft (6 mm in diameter).
Patients were eligible for inclusion if presenting with disabling claudication,
rest pain or tissue loss.
Follow-up was performed and included clinical examination and du-
plex ultrasonography at all scheduled intervals. All patients were treated with
warfarin.
The main end-point of this study was primary patency of the bypass
graft at 2, 5 and 10 years after implantation. Secondary end-points were
mortality, primary assisted patency and secondary patency. Cumulative
patency rates were calculated with life-table analysis and with log-rank test.
Results: After 5 years, the primary, primary assisted and secondary
patency rates were 36% (confidence interval (CI): 26–46%), 46% (CI:
36–56%) and 51% (CI: 41–61%) for ePTFE and 52% (CI: 42–62%)
(p  0.04), 66% (CI: 56–76%) (p  0.01) and 70% (CI: 60–80%)
(p  0.01) for Dacron, respectively. After ten years these rates were respec-
tively 28% (CI:18-38%), 31% (CI:19-43%) and 35% (CI: 23-47%) for ePTFE
and 28% (CI: 18-38%), 49% (CI: 37-61%) and 49% (CI: 37-61%) for
Dacron.
Conclusion:During prolonged follow-up (10 years), Dacron femoro-
popliteal bypass grafts have superior patency compared to those of ePTFE
grafts. Dacron is the graft material of choice if the saphenous vein is not
available.
Implementation of Endovenous Laser Ablation for Varicose Veins in a
Large Community Hospital: The First 400 Procedures
van den Bremer J., Hedeman Joosten P.Ph.A., Hamming J.F., Moll F.L.
Eur J Vasc Endovasc Surg 2009;xx:xx-xx.
Endovenous laser ablation (ELA) has become a standard treatment of
the incompetent great saphenous vein (GSV). Our prospective audit exam-
ines the implementation of this new method in a large community hospital
with special attention to obstacles, technical results, pain scores, failures and
our learning curve.
Methods: Three hundred and twenty-three patients (403 limbs) with
incompetence of the GSV underwent ELA. Patients were assessed by clinical
examination and venous duplex ultrasound was performed 6 weeks after
operation. Visual analog scale (VAS) pain scores of the first postoperative
week were recorded. Operative time and success rate were analysed.
Results:After 6weeks, 301 (74.7%) treated legswere examinedbyduplex
ultrasound imaging. Successful complete occlusion was present in 282 (93.7%)
GSVs. Partial occlusion was present in 12 (4.0%) GSVs. In seven (2.3%) limbs
the GSV was not occluded. The maximummean VAS pain score was noted on
the 5th postoperative day. From the start of this series, the operation time
decreased rapidly for each surgeon, stabilising after 15 limbs.
Conclusion: ELA of the incompetent GSV is effective and safe. ELA is
cacious method to improve the healing process in diabetic ischaemic ulcers.
However, beyond appropriate re-vascularisation, even repetitive if necessary,
simple to perform, well accepted by patients and relatively atraumatic. In our
opinion, ELA can be easily implemented in surgical practice.
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